PAREXEL Launches Impact Express Clinical Trial Management System

PAREXEL International Corporation introduced IMPACT Express Clinical Trial Management System (CTMS). IMPACT Express provides a quick-to-implement, cost-effective clinical trial management solution to simplify clinical trial management and monitoring for small to mid-sized biopharmaceutical companies.

Clinical trials are the most expensive component of the drug development process. Use of a single, unified clinical trial management system plays a vital role in helping biopharmaceutical companies’ plan, track, record, and oversee the complex array of administrative, financial, site-related, and other activities that are critical for the efficient monitoring and management of clinical trials.

“PAREXEL developed IMPACT Express for biopharmaceutical and biotech companies in need of a scalable, rapid-to-deploy and cost-effective CTMS option to intelligently manage the complexities of clinical trials,” said Patrick Nadolny, Vice President of Product Management, Data and Analytics Services, PAREXEL Informatics.  “By applying a process-driven approach to trial management and monitoring, biopharma companies will be better able to save time – and money – while simplifying their drug development journey.”

IMPACT Express draws on PAREXEL Informatics’ commitment to operational excellence and 20+ years of investment in CTMS innovations and process improvements coupled with the feedback and hands-on experiences of users around the world.  Biopharmaceutical, medical device and research organizations of all sizes have used PAREXEL’s CTMS solutions to manage more than 25,000 trials.